Home | Business News | Browse by Publication | C | Chemistry and Industry

UK speciality pharma concern BTG has sold its Hysolv drug delivery technology to Novartis Pharma for an initial payment of $750,000 and potential milestone payments of up to $9.25m.

Publication: Chemistry and Industry
Publication Date: 14-SEP-09
Format: Online
Delivery: Immediate Online Access
Full Article Title: UK speciality pharma concern BTG has sold its Hysolv drug delivery technology to Novartis Pharma for an initial payment of $750,000 and potential milestone payments of up to $9.25m.(Projects & Technology)(Brief article)

Article Excerpt
UK speciality pharma concern BTG has sold its...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Chemistry and Industry
Pfizer.(Projects & Technology)(Brief article), September 14, 2009
Two Dutch chemical majors head the chemicals segment of the 2009 Dow J..., September 14, 2009
Nitrous oxide.(Safety & Environment)(National Oceanic and Atmospheric ..., September 14, 2009
The UK has introduced new controls under the Misuse of Drugs Act for a..., September 14, 2009
Toolbox to Evaluate Sustainable Systems.(Safety & Environment)(Chemica..., September 14, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.